Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012 Apr;24(2):110-3.
doi: 10.3969/j.issn.1002-0829.2012.02.007.

Current status of clozapine in the United States

Deanna L Kelly  1 , Heidi J Wehring  1 , Gopal Vyas  1
Affiliations

Current status of clozapine in the United States

Deanna L Kelly et al. Shanghai Arch Psychiatry. 2012 Apr.
No abstract available

PubMed Disclaimer

Conflict of interest statement

Conflict of interest: The authors report no conflict of interest related to this manuscript. Dr. Deanna Kelly has received grant suppport from Bristol Myers Squibb, Ameritox, Ltd., and Janssen Pharmaceutica; Dr. Heidi Wehring has receive grant support from Janssen Pharmaceutica.

References

    1. Conley RR, Kelly DL. Management of treatment resistance in schizophrenia. Biol Psychiatry. 2001;50(11):898–911. - PubMed
    1. Brier A, Buchanan RW, Kirkpatrick B, Davis OR, Irish D, Summerfelt A, et al. Effects of clozapine on positive and negative symptoms in outpatients with schizophrenia. Am J Psychiatry. 1994;151(1):20–26. - PubMed
    1. Kane JM, Marder SR, Schooler NR, Wirshing WC, Umbricht D, Baker RW, et al. Clozapine and haloperidol in moderately refractory schizophrenia: a 6-month randomized and double-blind comparison. Arch Gen Psychiatry. 2001;58(10):965–972. - PubMed
    1. Azorin JM, Spiegel R, Remington G, Vanelle JM, Pere JJ, Guguere M, et al. A double-blind comparative study of clozapine and risperidone in the management of severe chronic schizophrenia. Am J Psychiatry. 2001;158(8):1305–1313. - PubMed
    1. Buchanan RW, Kreyenbuhl J, Kelly DL, Noel JM, Boggs DL, Fischer BA, et al. The 2009 schizophrenia PORT psychopharmacological treatment recommendations and summary statements. Schizophr Bull. 2010;36(1):71–93. - PMC - PubMed

LinkOut - more resources